Literature DB >> 2575320

A prospective immunofluorescence study of immune deposits in the skin of primary Sjögren's syndrome.

P J Velthuis1, C Nieboer, L Kater, R J Hené.   

Abstract

There are conflicting opinions concerning the epidermal immunofluorescence pattern in primary Sjögren's syndrome. In a prospective study of 12 patients we found a characteristic pattern of epidermal nuclear/cytoplasmic IgG deposits in 8 (67%). This pattern was associated with the presence of antibodies against SSA/Ro and SSB/La in the serum and was also found in 2 out of 5 LE patients with monospecific antibodies against SSA/Ro. There is a resemblance to the pattern of dust-like particles described in the diseased skin of patients with subacute cutaneous LE. In one patient with primary Sjögren's syndrome, IgG deposits were confined to epidermal cell nuclei (in vivo ANA). Instead of antibodies against SSA/Ro or SSB/La, this particular patient had nRNP-antibodies. From this study, we conclude that the epidermal IgG deposits in primary Sjögren's syndrome may represent antibody binding to the sites within epidermal cells where the respective antigens are located.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2575320

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   4.437


  3 in total

1.  Binding of antibodies to nonhistone nucleoproteins on keratinocytes in suspensions.

Authors:  P J Velthuis; E G Wildschut; H Baart de la Faille; W A van Vloten; H van Weelden; L Kater
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

2.  Epidermal cell surface-associated IgG in patients with primary Sjögren's syndrome: in vitro evidence for immune complex binding.

Authors:  P Oxholm; A Oxholm; B S Thomsen; L Braathen
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

3.  Immunofluorescence microscopy of healthy skin from patients with systemic lupus erythematosus: more than just the lupus band.

Authors:  P J Velthuis; L Kater; I van der Tweel; H B de la Faille; W A van Vloten
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.